Pitocin is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Oxytocin.
Product ID | 42023-130_168f1c8c-8f83-46d2-8f06-15c0c69f3bf5 |
NDC | 42023-130 |
Product Type | Human Prescription Drug |
Proprietary Name | Pitocin |
Generic Name | Oxytocin |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2018-05-01 |
Marketing Category | NDA / NDA |
Application Number | NDA018261 |
Labeler Name | Par Pharmaceutical, Inc. |
Substance Name | OXYTOCIN |
Active Ingredient Strength | 10 [iU]/mL |
Pharm Classes | Increased Uterine Smooth Muscle Contraction or Tone [PE],Oxytocic [EPC],Oxytocin [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-05-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA018261 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-05-01 |
Ingredient | Strength |
---|---|
OXYTOCIN | 10 [iU]/mL |
SPL SET ID: | 6d4b2c25-2e5d-49b5-93bc-2ae8a20916d1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
42023-116 | Pitocin | oxytocin |
42023-130 | Pitocin | oxytocin |
0143-9742 | Oxytocin | Oxytocin |
0143-9743 | Oxytocin | Oxytocin |
0641-6114 | Oxytocin | Oxytocin |
0641-6115 | Oxytocin | Oxytocin |
52533-048 | Oxytocin | Oxytocin |
52533-051 | Oxytocin | Oxytocin |
52533-054 | Oxytocin | Oxytocin |
52533-055 | Oxytocin | Oxytocin |
52533-056 | Oxytocin | Oxytocin |
52533-105 | Oxytocin | Oxytocin |
52533-170 | Oxytocin | Oxytocin |
52533-233 | Oxytocin | Oxytocin |
52533-234 | Oxytocin | Oxytocin |
55154-9356 | Oxytocin | OXYTOCIN |
55154-9577 | Oxytocin | OXYTOCIN |
55154-9584 | Oxytocin | OXYTOCIN |
63323-012 | Oxytocin | OXYTOCIN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PITOCIN 71274724 0254956 Live/Registered |
PARKE, DAVIS & COMPANY 1928-11-02 |